Suppr超能文献

肝脏X受体:一种新型治疗靶点。

Liver x receptor: a novel therapeutic target.

作者信息

Patel M B, Oza N A, Anand I S, Deshpande S S, Patel C N

机构信息

Department of Pharmacology, Shri Sarvajanik Pharmacy College, Near Arvind Baug, Mehsana - 384 001, India.

出版信息

Indian J Pharm Sci. 2008 Mar-Apr;70(2):135-44. doi: 10.4103/0250-474X.41445.

Abstract

The liver X receptors alpha and beta are orphan nuclear receptors that are key regulators in maintaining cholesterol homeostasis. Originally they were found to play an important role in reverse cholesterol transport, a pathway for the removal of excess cellular cholesterol. However several groups have now shown that the liver X receptors also functions in lipid and carbohydrate metabolism, cellular differentiation, apoptosis and many immune responses. Tissue distribution of the two paralogues differs with liver X receptor beta ubiquitously expressed, while liver X receptor alpha is confined to the liver, kidney, intestine, spleen, adipose tissue, macrophages and skeletal muscle. The endogenous ligands for the liver X receptors are certain oxidized derivatives of cholesterol, the oxysterols. Upon activation by oxysterols, the receptors form obligate heterodimers with retinoid X receptors alpha, beta and gamma; and become competent to activate the transcription of target genes.

摘要

肝脏X受体α和β是孤儿核受体,是维持胆固醇稳态的关键调节因子。最初发现它们在胆固醇逆向转运中起重要作用,胆固醇逆向转运是清除细胞内多余胆固醇的一条途径。然而,现在有几个研究小组表明,肝脏X受体在脂质和碳水化合物代谢、细胞分化、细胞凋亡以及许多免疫反应中也发挥作用。这两种同源物的组织分布有所不同,肝脏X受体β广泛表达,而肝脏X受体α则局限于肝脏、肾脏、肠道、脾脏、脂肪组织、巨噬细胞和骨骼肌。肝脏X受体的内源性配体是胆固醇的某些氧化衍生物,即氧化甾醇。在被氧化甾醇激活后,这些受体与视黄醇X受体α、β和γ形成 obligate异二聚体;并能够激活靶基因的转录。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26dc/2792482/562e9fe6f255/IJPhS-70-135-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验